Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment

Detalles Bibliográficos
Autores principales: Kate Gadanec, Laura, Qaradakhi, Tawar, Renee McSweeney, Kristen, Ashiana Ali, Benazir, Zulli, Anthony, Apostolopoulos, Vasso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885526/
https://www.ncbi.nlm.nih.gov/pubmed/33569984
http://dx.doi.org/10.2217/fmb-2021-0018
_version_ 1783651623519649792
author Kate Gadanec, Laura
Qaradakhi, Tawar
Renee McSweeney, Kristen
Ashiana Ali, Benazir
Zulli, Anthony
Apostolopoulos, Vasso
author_facet Kate Gadanec, Laura
Qaradakhi, Tawar
Renee McSweeney, Kristen
Ashiana Ali, Benazir
Zulli, Anthony
Apostolopoulos, Vasso
author_sort Kate Gadanec, Laura
collection PubMed
description
format Online
Article
Text
id pubmed-7885526
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-78855262021-02-16 Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment Kate Gadanec, Laura Qaradakhi, Tawar Renee McSweeney, Kristen Ashiana Ali, Benazir Zulli, Anthony Apostolopoulos, Vasso Future Microbiol Editorial Future Medicine Ltd 2021-02-11 2021-01 /pmc/articles/PMC7885526/ /pubmed/33569984 http://dx.doi.org/10.2217/fmb-2021-0018 Text en © 2021 Future Medicine Ltd This work is licensed under the Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0/)
spellingShingle Editorial
Kate Gadanec, Laura
Qaradakhi, Tawar
Renee McSweeney, Kristen
Ashiana Ali, Benazir
Zulli, Anthony
Apostolopoulos, Vasso
Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment
title Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment
title_full Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment
title_fullStr Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment
title_full_unstemmed Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment
title_short Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment
title_sort dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to sars-cov-2 treatment
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885526/
https://www.ncbi.nlm.nih.gov/pubmed/33569984
http://dx.doi.org/10.2217/fmb-2021-0018
work_keys_str_mv AT kategadaneclaura dualtargetingoftolllikereceptor4andangiotensinconvertingenzyme2aproposedapproachtosarscov2treatment
AT qaradakhitawar dualtargetingoftolllikereceptor4andangiotensinconvertingenzyme2aproposedapproachtosarscov2treatment
AT reneemcsweeneykristen dualtargetingoftolllikereceptor4andangiotensinconvertingenzyme2aproposedapproachtosarscov2treatment
AT ashianaalibenazir dualtargetingoftolllikereceptor4andangiotensinconvertingenzyme2aproposedapproachtosarscov2treatment
AT zullianthony dualtargetingoftolllikereceptor4andangiotensinconvertingenzyme2aproposedapproachtosarscov2treatment
AT apostolopoulosvasso dualtargetingoftolllikereceptor4andangiotensinconvertingenzyme2aproposedapproachtosarscov2treatment

Ejemplares similares